SEC Form 4 · accession 0000899243-17-007750
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gert L. Perlhagen
Director
Period of report
Mar 14, 2017
Accepted (ET)
Mar 16, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 14, 2017 | P | 125,000 | $6.93 | A | 6,125,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 14, 2017, Mr. Perlhagen purchased 125,000 shares in multiple trades at prices ranging from $6.825 to $7.05. The price reported above reflects the weighted average purchase price. Mr. Perlhagen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.